Find a Research Expert

Experts
 Menu

Denis M Collins

Institution

Dublin City University

Contact

Subjects

Microbiology

Biochemistry

Pharmacology

Details
Publications 26
As first author 9
As last author 2
Unique topics 220
Collaborations 57
Sources 9
Are you Denis M Collins? Click here to provide feedback on your profile.
All
2019
2018
2017
2015
2014
2012
2011
2010
2009
Earlier
All
2019
2018
2017
2015
2014
2012
2011
2010
2009
Earlier

2019

Acquired Resistance to Antibody-Drug Conjugates.
2019

Novel Strategies for Cancer Treatment: Highlights from the 55th IACR Annual Conference.
2019

Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and
2018

HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer.
2018

Innovative technologies changing cancer treatment
2018

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial.
2017

Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.
2017

The HSP90 inhibitor NVP-AUY922 inhibits growth of HER2 positive and trastuzumab-resistant breast cancer cells.
2017

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.
2015

HER2-family signalling mechanisms, clinical implications and targeting in breast cancer.
2015

Kinase inhibitor screening identifies CDK4 as a potential therapeutic target for melanoma.
2014

HER2-family signalling mechanisms, clinical implications and targeting in breast cancer.
2014

Prostaglandin D2 regulates human colonic ion transport via the DP1 receptor.
2012

The mycotoxin patulin increases colonic epithelial permeability in vitro.
2011

Src: a potential target for the treatment of triple-negative breast cancer.
2011

Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines.
2011

Tuberculosis in cattle herds are sentinels for Mycobacterium bovis infection in European badgers (Meles meles): the Irish Greenfield Study.
2010

Artificial neural networks for classification in metabolomic studies of whole cells using 1H nuclear magnetic resonance.
2010

Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis
2010

Modulation of P-gp expression by lapatinib.
2009

Cyclic AMP-mediated chloride secretion is induced by prostaglandin F2alpha in human isolated colon.
2009

Lapatinib: a competitor or companion to trastuzumab?
2009

Tyrosine kinase inhibitors potentiate the cytotoxicity of MDR-substrate anticancer agents independent of growth factor receptor status in lung cancer cell lines.
2008

Docetaxel uptake and modulation of P-gpmediated docetaxel efflux by tyrosine kinase inhibitors in human lung carcinoma cell lines
2008

Metabolomic studies of human lung carcinoma cell lines using in vitro (1)H NMR of whole cells and cellular extracts.
2005

Preoperative characteristics identify patients with hip fractures at risk of transfusion.

These arethe9 unique sources for Denis M Collins's 26 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.

Source #
Ireland -> Dublin City University 17
Ireland -> Dublin City University -> PubMed 15
Ireland -> Royal College of Surgeons in Ireland 3
Ireland -> Royal College of Surgeons in Ireland -> PubMed 2
Ireland -> Trinity College Dublin 4
Ireland -> Trinity College Dublin -> PubMed 1
Ireland -> University College Dublin 5
Ireland -> University College Dublin -> PubMed 4
Ireland -> University of Limerick 1

  1. Further insights

    Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.

  2. Details

    Here is a quick breakdown of this expert's publication history

  3. Contact

    If this is the expert you have been looking for, simply click here to make contact.